0001660410-19-000001.txt : 20190104 0001660410-19-000001.hdr.sgml : 20190104 20190104160928 ACCESSION NUMBER: 0001660410-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 EFFECTIVENESS DATE: 20190104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ribon Therapeutics, Inc. CENTRAL INDEX KEY: 0001660410 IRS NUMBER: 473651475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-329723 FILM NUMBER: 19510107 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING D, SUITE 100 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-914-8700 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING D, SUITE 100 CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001660410 Ribon Therapeutics, Inc. 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA MASSACHUSETTS 02421 617-914-8700 DELAWARE None None Corporation true 2015 Svennilson Peter 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Victoria M. Richon 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Jonathan Root 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Cameron Wheeler 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director David Cordo 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Executive Officer James Audia 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Marian Nakada 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Anja Koenig 99 Hayden Avenue Building D, Suite 100 Lexington MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2018-12-21 false true false 0 65000000 25415384 39584616 false 10 0 0 0 false Ribon Therapeutics, Inc. /s/ Victoria M. Richon, Ph.D. Victoria M. Richon, Ph.D. President and Chief Executive Officer 2019-01-04